CompaniesRanked

2874 companies · fiscal year 2025 · SEC EDGAR · September 25, 2026

Largest healthcare companies by total assets — page 2

Ranks 101–200 of 321 · Fiscal year 2025 · Data as of September 25, 2026

Total assets
#CompanyTotal assetsYoY15-year trend
101Lakefront BiotherapeuticsLKFTBE$4.0B−6.8%
102Bright Horizons Family SolutionsBFAMUS$3.9B+1.0%
103EnovisENOVUS$3.8B−18.7%
104RadnetRDNTUS$3.8B+14.4%
105Kindercare Learning CompaniesKLCUS$3.7B+2.8%
106Amneal PharmaceuticalsAMRXUS$3.7B+5.1%
107Integra LifesciencesIARTUS$3.6B−10.8%
108Ionis PharmaceuticalsIONSUS$3.5B+17.3%
109Prestige Consumer HealthcarePBHUS$3.5B+5.0%
110Option Care HealthOPCHUS$3.5B+1.0%
111Integer HoldingsITGRUS$3.4B+10.8%
112NeogenNEOGUS$3.4B−17.1%
113Idexx LaboratoriesIDXXUS$3.4B+1.7%
114Sarepta TherapeuticsSRPTUS$3.3B−15.5%
115Sotera HealthSHCUS$3.3B+6.2%
116InsuletPODDUS$3.2B+3.3%
117Stevanato GroupSTVNIT$3.0B+23.5%
118RepligenRGENUS$2.9B+4.2%
119GrailGRALUS$2.9B−2.1%
120PTC TherapeuticsPTCTUS$2.9B+70.0%
121Concentra Group Holdings ParentCONUS$2.9B+13.4%
122Teladoc HealthTDOCUS$2.9B−18.7%
123Curaleaf HoldingsCURLFUS$2.8B−3.5%
124ExelixisEXELUS$2.8B−3.5%
125HerbalifeHLFKY$2.8B+2.1%
126Fortrea HoldingsFTREUS$2.7B−24.1%
127Trulieve CannabisTRLVUS$2.7B−6.1%
128Merit Medical SystemsMMSIUS$2.7B+11.1%
129LivanovaLIVNGB$2.6B+4.0%
130Msa SafetyMSAUS$2.6B+15.8%
131Halozyme TherapeuticsHALOUS$2.5B+22.4%
132Bio-TechneTECHUS$2.5B−5.5%
133HaemoneticsHAEUS$2.5B−1.6%
134AlkermesALKSIE$2.5B+21.0%
135NateraNTRAUS$2.4B+44.4%
136ConmedCNMDUS$2.3B+0.8%
137InsmedINSMUS$2.3B+11.8%
138Pediatrix MedicalMDUS$2.2B+4.4%
139Lantheus HoldingsLNTHUS$2.2B+12.5%
140Lifestance HealthLFSTUS$2.2B+4.0%
141Hims & Hers HealthHIMSUS$2.2B+204.5%
142Tilray BrandsTLRYUS$2.1B−39.0%
143Guardant HealthGHUS$2.0B+35.5%
144Aveanna HealthcareAVAHUS$2.0B+21.0%
145National VisionEYEUS$2.0B−1.2%
146Medpace HoldingsMEDPUS$2.0B−6.0%
147Opko HealthOPKUS$1.9B−12.2%
148PenumbraPENUS$1.8B+19.1%
149HUTCHMED (China)HCMHK$1.8B+37.6%
150Legend BiotechLEGNUS$1.7B+3.8%
151Collegium PharmaceuticalCOLLUS$1.7B−0.4%
152InnovivaINVAUS$1.6B+25.7%
153Amphastar PharmaceuticalsAMPHUS$1.6B+3.3%
154Arrowhead PharmaceuticalsARWRUS$1.6B+58.3%
155Acadia PharmaceuticalsACADUS$1.6B+31.7%
156Ligand PharmaceuticalsLGNDUS$1.6B+65.7%
157ChemedCHEUS$1.5B−7.8%
158Ultragenyx PharmaceuticalRAREUS$1.5B+1.9%
159Ascendis PharmaASNDDK$1.5B+24.9%
160National HealthcareNHCUS$1.5B+0.1%
161AlvotechALVOLU$1.5B+21.8%
162Beam TherapeuticsBEAMUS$1.5B+34.2%
163Supernus PharmaceuticalsSUPNUS$1.5B+6.2%
164Ani PharmaceuticalsANIPUS$1.4B+12.1%
165Addus HomecareADUSUS$1.4B+1.7%
166VeracyteVCYTUS$1.4B+8.2%
167Phibro Animal HealthPAHCUS$1.4B+9.3%
168Nu Skin EnterprisesNUSUS$1.4B−4.3%
169Privia HealthPRVAUS$1.4B+20.6%
170Krystal BiotechKRYSUS$1.3B+26.3%
171Emergent BiosolutionsEBSUS$1.3B−5.1%
172Harmony BiosciencesHRMYUS$1.3B+27.3%
173Agilon HealthAGLUS$1.3B−26.7%
174Pacira BiosciencesPCRXUS$1.3B−18.6%
175Madrigal PharmaceuticalsMDGLUS$1.3B+20.9%
176Fulgent GeneticsFLGTUS$1.2B−0.5%
177U S Physical TherapyUSPHUS$1.2B+3.1%
178Indivior PharmaceuticalsINDVUS$1.2B−8.7%
179Cresco LabsCRLBFUS$1.2B−11.7%
180Cronos GroupCRONCA$1.2B+2.6%
181NovavaxNVAXUS$1.2B−24.6%
182Zai LabZLABCN$1.2B−1.1%
183Telix PharmaceuticalsTLXAU$1.2B+23.8%
184Arcus BiosciencesRCUSUS$1.1B−1.0%
185Caris Life SciencesCAIUS$1.1B+227.5%
186Ginkgo BioworksDNAUS$1.1B−18.7%
187Ideaya BiosciencesIDYAUS$1.1B−1.3%
188Catalyst PharmaceuticalsCPRXUS$1.1B+29.7%
189Avanos MedicalAVNSUS$1.1B−7.0%
190Transmedics GroupTMDXUS$1.1B+32.9%
191Immunocore HoldingsIMCRGB$1.1B+5.7%
192Alignment HealthcareALHCUS$1.1B+36.3%
193EmbectaEMBCUS$1.1B−7.5%
194TG TherapeuticsTGTXUS$1.1B+84.1%
195Irhythm HoldingsIRTCUS$1.0B+9.5%
196SNDLSNDLCA$976M+4.0%
197Pennant GroupPNTGUS$968M+42.5%
198Bridgebio PharmaBBIOUS$936M+1.8%
199TrupanionTRUPUS$915M+13.4%
200Iovance BiotherapeuticsIOVAUS$913M+0.3%

All figures from SEC filings · FY2025 · 100

see sources

Download this data as a CSV →

Largest companies by total assets →

By sector

By country